# Sigma Pharmaceuticals Ltd: Form D filing

Sigma Pharmaceuticals Ltd, a pharmaceuticals company in South Croydon, Victoria, filed a Form D with the SEC in 2009. The latest, on September 24, 2009, reports $18.2 million sold of a $18.2 million offering to 13 investors.

Find out what Sigma Pharmaceuticals Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Sigma%20Pharmaceuticals%20Ltd%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Sigma%20Pharmaceuticals%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fsigma-pharmaceuticals-ltd-1472870)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Sigma%20Pharmaceuticals%20Ltd%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Sigma%20Pharmaceuticals%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fsigma-pharmaceuticals-ltd-1472870)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 96 MERRINDALE DRIVE, South Croydon, Victoria, 3136
- Phone: 61 3 9839 2800
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Australia
- Revenue range: Over $100,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1472870

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 24, 2009 | New notice | $18,215,562 | $18,215,562 | $0 | 13 | Sep 23, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1472870/000147287009000002/0001472870-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Robert Ellis | Executive Officer |  |
| Linda B Nicholls | Director |  |
| David S Bayes | Director |  |
| Craig Tomlinson | Executive Officer |  |
| Geoffrey D W Curlewis | Director |  |
| Michael Long | Executive Officer |  |
| Elmo de Alwis | Director |  |
| James Barrie | Executive Officer |  |
| Ian Finlay | Executive Officer |  |
| Sue Morgan Dethick | Executive Officer |  |
| Mark Smith | Executive Officer |  |
| William J Scott | Director |  |
| Jackie Toh | Executive Officer |  |
| John W Stocker AO | Director |  |
| Steve Waller | Executive Officer |  |
| Keith Jeffs | Executive Officer |  |
| Brian Jamieson | Director |  |
| Peter Tilley | Executive Officer |  |

[Every Form D from the week of Sep 21, 2009](https://specstream.ai/data/form-d/week/2009-09-21) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Sigma Pharmaceuticals Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).